CE vs COR
Celanese Corporation (CE) versus Cencora Inc. (COR) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
CE currently screens at market cap $5.92B. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Not investment advice. Open the CE and COR stock pages for the full models.
Not investment advice.